268 related articles for article (PubMed ID: 1963340)
1. Reduction by central beta-funaltrexamine of food intake in rats under freely-feeding, deprivation and glucoprivic conditions.
Arjune D; Standifer KM; Pasternak GW; Bodnar RJ
Brain Res; 1990 Dec; 535(1):101-9. PubMed ID: 1963340
[TBL] [Abstract][Full Text] [Related]
2. General, mu and kappa opioid antagonists in the nucleus accumbens alter food intake under deprivation, glucoprivic and palatable conditions.
Bodnar RJ; Glass MJ; Ragnauth A; Cooper ML
Brain Res; 1995 Nov; 700(1-2):205-12. PubMed ID: 8624711
[TBL] [Abstract][Full Text] [Related]
3. Selective alterations in macronutrient intake of food-deprived or glucoprivic rats by centrally-administered opioid receptor subtype antagonists in rats.
Koch JE; Bodnar RJ
Brain Res; 1994 Sep; 657(1-2):191-201. PubMed ID: 7820618
[TBL] [Abstract][Full Text] [Related]
4. Ingestive behavior following central [D-Ala2, Leu5, Cys6]-enkephalin (DALCE), a short-acting agonist and long-acting antagonist at the delta opioid receptor.
Arjune D; Bowen WD; Bodnar RJ
Pharmacol Biochem Behav; 1991 Jun; 39(2):429-36. PubMed ID: 1658817
[TBL] [Abstract][Full Text] [Related]
5. Beta-funaltrexamine (beta-FNA) decreases deprivation and opioid-induced feeding.
Levine AS; Grace M; Billington CJ
Brain Res; 1991 Oct; 562(2):281-4. PubMed ID: 1663414
[TBL] [Abstract][Full Text] [Related]
6. Effects of intracerebroventricular beta-funaltrexamine on mu and delta opioid receptors in the rat: dichotomy between binding and antinociception.
Liu-Chen LY; Li SX; Wheeler-Aceto H; Cowan A
Eur J Pharmacol; 1991 Oct; 203(2):195-202. PubMed ID: 1666046
[TBL] [Abstract][Full Text] [Related]
7. Different central opioid receptor subtype antagonists modify maltose dextrin and deprivation-induced water intake in sham feeding and sham drinking rats.
Leventhal L; Bodnar RJ
Brain Res; 1996 Nov; 741(1-2):300-8. PubMed ID: 9001736
[TBL] [Abstract][Full Text] [Related]
8. Alterations in deprivation, glucoprivic and sucrose intake following general, mu and kappa opioid antagonists in the hypothalamic paraventricular nucleus of rats.
Koch JE; Glass MJ; Cooper ML; Bodnar RJ
Neuroscience; 1995 Jun; 66(4):951-7. PubMed ID: 7651622
[TBL] [Abstract][Full Text] [Related]
9. Mercaptoacetate induces feeding through central opioid-mediated mechanisms in rats.
Stein JA; Znamensky V; Baumer F; Rossi GC; Pasternak GW; Bodnar RJ
Brain Res; 2000 May; 864(2):240-51. PubMed ID: 10802031
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of opioid receptor subtype antagonist effects in the ventral tegmental area upon food intake under deprivation, glucoprivic and palatable conditions.
Ragnauth A; Ruegg H; Bodnar RJ
Brain Res; 1997 Aug; 767(1):8-16. PubMed ID: 9365010
[TBL] [Abstract][Full Text] [Related]
11. Effects of beta-funaltrexamine on ingestive behaviors in the rat.
Ukai M; Holtzman SG
Eur J Pharmacol; 1988 Aug; 153(2-3):161-5. PubMed ID: 2846315
[TBL] [Abstract][Full Text] [Related]
12. Suppression of nocturnal, palatable and glucoprivic intake in rats by the kappa opioid antagonist, nor-binaltorphamine.
Arjune D; Bodnar RJ
Brain Res; 1990 Nov; 534(1-2):313-6. PubMed ID: 1963562
[TBL] [Abstract][Full Text] [Related]
13. Central opioid receptor subtype antagonists differentially reduce intake of saccharin and maltose dextrin solutions in rats.
Beczkowska IW; Koch JE; Bostock ME; Leibowitz SF; Bodnar RJ
Brain Res; 1993 Aug; 618(2):261-70. PubMed ID: 8397050
[TBL] [Abstract][Full Text] [Related]
14. General, kappa, delta and mu opioid receptor antagonists mediate feeding elicited by the GABA-B agonist baclofen in the ventral tegmental area and nucleus accumbens shell in rats: reciprocal and regional interactions.
Miner P; Shimonova L; Khaimov A; Borukhova Y; Ilyayeva E; Ranaldi R; Bodnar RJ
Brain Res; 2012 Mar; 1443():34-51. PubMed ID: 22305145
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of opioid systems in the hypothalamus as well as the mesolimbic area suppresses feeding behavior of mice.
Ikeda H; Ardianto C; Yonemochi N; Yang L; Ohashi T; Ikegami M; Nagase H; Kamei J
Neuroscience; 2015 Dec; 311():9-21. PubMed ID: 26454026
[TBL] [Abstract][Full Text] [Related]
16. The effect of selective opioid antagonists on butorphanol-induced feeding.
Levine AS; Grace M; Portoghese PS; Billington CJ
Brain Res; 1994 Feb; 637(1-2):242-8. PubMed ID: 8180802
[TBL] [Abstract][Full Text] [Related]
17. Involvement of mu1 and mu2 opioid receptor subtypes in tail-pinch feeding in rats.
Koch JE; Bodnar RJ
Physiol Behav; 1993 Mar; 53(3):603-5. PubMed ID: 8383858
[TBL] [Abstract][Full Text] [Related]
18. Chronic prevention of mu-opioid receptor (MOR) G-protein coupling in the pontine parabrachial nucleus persistently decreases consumption of standard but not palatable food.
Ward HG; Simansky KJ
Psychopharmacology (Berl); 2006 Sep; 187(4):435-46. PubMed ID: 16847679
[TBL] [Abstract][Full Text] [Related]
19. Differential modulation of angiotensin II and hypertonic saline-induced drinking by opioid receptor subtype antagonists in rats.
Ruegg H; Hahn B; Koch JE; Bodnar RJ
Brain Res; 1994 Jan; 635(1-2):203-10. PubMed ID: 8173956
[TBL] [Abstract][Full Text] [Related]
20. Assessment of relative intrinsic activity of mu-opioid analgesics in vivo by using beta-funaltrexamine.
Adams JU; Paronis CA; Holtzman SG
J Pharmacol Exp Ther; 1990 Dec; 255(3):1027-32. PubMed ID: 2175793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
